Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib

被引：32

作者：

Breccia, M ^{[1
]}

D'Elia, GM ^{[1
]}

D'Andrea, M ^{[1
]}

Latagliata, R ^{[1
]}

Alimena, G ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2005年 / 74卷 / 01期

关键词：

D O I：

10.1111/j.1600-0609.2004.00347.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：89 / 90

页数：2

共 4 条

[1] Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia [J].

Barton, JC ;

Jones, SC ;

Lamberth, WC ;

Reymann, MT ;

Scott, VC .

AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (02) :139-140

[2] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[3] Imatinib treatment: Specific issues related to safety, fertility, and pregnancy [J].

Hensley, ML ;

Ford, JM .

SEMINARS IN HEMATOLOGY, 2003, 40 (02) :21-25

[4] Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses [J].

Kantarjian, HM ;

Cortes, JE ;

O'Brien, S ;

Giles, F ;

Garcia-Manero, G ;

Faderl, S ;

Thomas, D ;

Jeha, S ;

Rios, B ;

Letvak, L ;

Bochinski, K ;

Arlinghaus, R ;

Talpaz, M .

BLOOD, 2003, 101 (01) :97-100

← 1 →